Evidence map›Paper›PMID 31366597›Full record

ArticleBMJ (Clinical research ed.)2019

CONSORT 2010 statement: extension to randomised crossover trials.

Kerry Dwan, Tianjing Li, Douglas G Altman, Diana Elbourne

6 registry-linked trialsAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 409 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
409citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06381947 phase4unknown statusstarted 2024, after this paper: background citation

Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients: a Randomized Crossover Trial

Ran2024Enrolled130Registered outcomes19Posted comparisons0ConditionsCardiovascular Diseases, Dyslipidemias, Lipid Metabolism Disorders, Statin Adverse ReactionArmsLipid-lowering therapy combination with PCSK9 inhibitors and ezetimibe, Lipid-lowering therapy combination with PCSK9 inhibitors, bempedoic acid and ezetimibe
Open the trial in the graph
NCT05963802 nacompletednot on this mapstarted 2023, after this paper: background citation

Crossover Randomized Controlled Trial to Evaluate the Efficacy and Usability of Artificial Intelligence (ChatGPT) for Health Sciences Students (AIHSS)

TypeinterventionalSponsorCarleton UniversityRan2023 to 2023Enrolled26ConditionsEducational Activities, AI (Artificial Intelligence)ArmsArtificial Intelligence (ChatGPT) Group
NCT06737276 nacompletednot on this mapstarted 2022, after this paper: background citation

Dietary Advice Training in Nursing Using Simulation and Interactive Fiction: a Randomised Controlled Trial

TypeinterventionalSponsorUniversity of CadizRan2022 to 2022Enrolled60ConditionsSimulation Training, Computer Simulation, Diet, Food, and Nutrition, Nutrition AssessmentArmsInteractive fiction activities, Role-play simulation
NCT07190989 nacompletednot on this mapstarted 2025, after this paper: background citation

Inter-individual Variability of Sleep Outcome Measures in Response to Nutritional Blend Supplementation: a Replicate Crossover Trial

TypeinterventionalSponsorAspire AcademyRan2025 to 2025Enrolled15ConditionsHealthyArmsNutritional Supplement, Maltodextrin (Placebo)
NCT07284303 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effect of an Automatic Infant Swing on Sleep-Wake Cycles, Comfort Behaviors, and Physiological Parameters in Newborns: A Randomized Controlled Trial

TypeinterventionalSponsorKirsehir Ahi Evran UniversitesiRan2025 to 2026Enrolled40ConditionsSleep QualityArmsCare: Automatic Baby Swing
NCT07625475 nacompletednot on this mapstarted 2024, after this paper: background citation

Session-order Sensitivity of Temporal Summation and Offset Analgesia in a Randomised Crossover Capsaicin Model of Secondary Hyperalgesia

TypeinterventionalSponsorUniversity of GuelphRan2024 to 2025Enrolled16ConditionsHyperalgesia, Pain Perception, Central Nervous System Sensitization, Pain ThresholdArmsTopical 0.075% capsaicin cream (Zostrix), Topical vehicle lotion (Lubriderm)
3 · Its place in the literature

Who cites it

409 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Effect of breaking up prolonged sitting with physical activity on executive function: a three-level meta-analysis.The international journal of behavioral nutrition and physical activity · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

349 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kerry DwanReview Production and Quality Unit, Editorial and Methods Department, Cochrane Central Executive, Cochrane, St Alban's House, London SW1Y 4QX, UK kdwan@cochrane.org.ORCID http://orcid.org/0000-0001-6918-1215
Tianjing LiCenter for Clinical Trials and Evidence Synthesis, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Douglas G AltmanCentre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Diana ElbourneLondon School of Hygiene and Tropical Medicine, Department of Medical Statistics, London, UK.

Funding

Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US ProjectUG1EY020522 · NEI · UNIVERSITY OF COLORADO DENVER · PI Tianjing Li · 2017 to 2026
$10.1M
NEI NIH HHS UG1 EY020522
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cross-Over StudiesData Interpretation, StatisticalPublishingRandomized Controlled Trials as TopicResearch Design

Identifiers

PMID31366597
PMCPMC6667942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.